To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
Clinical trial NCT05854381 · COMPLETED
Trial details
- NCT number
- NCT05854381
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2025-09-19
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.